Dr.ย Soon Thyeย Lim
MBBS, MRCP (UK), FAMS, Grad. Dip. Healthcare Management & Leadership
CEO & Senior Consultant, Medical Oncology
corporate_fareNational Cancer Centre Singapore, Singapore
Soon Thye Lim
MBBS, MRCP (UK), FAMS, Grad. Dip. Healthcare Management & Leadership
Prof. Lim Soon Thye is Chief Executive Officer and Senior Consultant at National Cancer Centre Singapore (NCCS), where he specialises in the diagnosis and treatment of lymphoma and lymphoid malignancies. He also serves as Senior Consultant at the SingHealth Duke-NUS Blood Cancer Centre.
Prof. Lim completed his MBBS at the National University of Singapore in 1994 and obtained his MRCP from the Royal College of Physicians, UK, in 2000. He subsequently trained in lymphoid malignancies at the University of Southern California, deepening his subspecialty focus. Over more than 30 years in oncology, he has built a distinguished career combining clinical practice with research leadership, including co-founding the Asian Lymphoma Study Group โ a collaborative network of academic medical centres across Asia. His translational research programme, funded by the National Medical Research Council, focuses on lymphoma genomics and the development of novel therapeutics for T-cell and NK/T-cell lymphomas.
CancerFax can coordinate medical report review and consultation support for international patients seeking a lymphoma opinion from Prof. Lim Soon Thye at National Cancer Centre Singapore, subject to hospital availability and case acceptance.
Why Consider Prof. Lim Soon Thye?
Prof. Lim Soon Thye is one of Singapore's foremost lymphoma specialists, combining over 30 years of clinical oncology experience with leading translational research in T-cell and NK/T-cell lymphomas โ subtypes that are particularly prevalent in Asia.
Areas of Specialisation
Expert in lymphoid malignancies and translational lymphoma research
Prof. Lim Soon Thye's clinical and research work is focused on the full spectrum of lymphoid malignancies, with particular depth in T-cell and NK/T-cell lymphomas that are more common across Asian populations.
Lymphoma & Lymphoid Malignancies
Comprehensive diagnostic and treatment planning for lymphoma subtypes, including those more prevalent in Asia.
- arrow_rightPeripheral T-cell lymphoma (PTCL) diagnosis and treatment planning
- arrow_rightBiomarker identification and novel therapeutic approaches
- arrow_rightGenomics-guided clinical management
- arrow_rightExtranodal NK/T-cell lymphoma management
- arrow_rightTranslational research connecting genomics to therapeutics
- arrow_rightAsian-focused epidemiology and treatment data
- arrow_rightDiffuse large B-cell lymphoma (DLBCL) treatment planning
- arrow_rightHIV-related and AIDS-associated lymphoma
- arrow_rightBroad lymphoma subspecialty coverage within NCCS
Blood Cancer & Haematological Oncology
Specialist input within the SingHealth Duke-NUS Blood Cancer Centre covering lymphoma and related haematological conditions.
- arrow_rightSenior Consultant at SingHealth Duke-NUS Blood Cancer Centre
- arrow_rightMultidisciplinary blood cancer case review and treatment coordination
Procedures & Clinical Services
Lymphoma treatment, research coordination and multidisciplinary care
Prof. Lim Soon Thye's clinical services are centred on the management of lymphoma and lymphoid malignancies, from initial staging and diagnosis through to systemic treatment, stem cell transplant coordination and second-opinion assessment.
Systemic Lymphoma Treatment
Medical OncologyChemotherapy regimens and novel systemic agents for lymphoma management.
Radiation Therapy Coordination
MultidisciplinaryCoordination of radiation therapy within multidisciplinary lymphoma treatment planning.
Stem Cell Transplant Pathway
TransplantStem cell transplant as a component of lymphoma treatment for eligible patients.
Lymphoma Diagnosis & Staging
DiagnosisDiagnostic evaluation and molecular staging to guide accurate lymphoma classification and treatment planning.
Second Opinion โ Lymphoma
Second OpinionIndependent expert review for patients diagnosed with lymphoma or seeking an alternative treatment opinion.
Research & Publications
Lymphoma translational research and academic contributions
Prof. Lim's research is focused on malignant lymphomas, particularly novel biomarkers and therapeutics in T-cell lymphomas. His Google Scholar profile records over 11,000 citations, an h-index of 57 and an i10-index of 157.
Prof. Lim's academic profile includes over 11,000 citations and an h-index of 57 (Google Scholar). A full publication list is available through Duke-NUS Medical School and PubMed.
Education & Training
Prof. Lim Soon Thye trained in Singapore and the United Kingdom, completing his specialist medical oncology training at NCCS and a focused lymphoid malignancy fellowship in the United States.
Clinical Experience
Prof. Lim Soon Thye has spent his career at National Cancer Centre Singapore, rising to Chief Executive Officer and Senior Consultant. He holds concurrent leadership roles across NCCS, SingHealth and Duke-NUS Medical School.
Languages & International
Prof. Lim Soon Thye conducts consultations in the following language.
CancerFax can coordinate professional medical interpreter support for international patients where required.
CancerFax can coordinate professional medical interpreter support for international patients consulting in other languages.
How CancerFax Helps You Access Dr. Soon Thye Lim
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Soon Thye Lim's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Soon Thye Lim's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Soon Thye Lim before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Soon Thye Lim's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Soon Thye Lim's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Soon Thye Lim's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Lim Soon Thye
Prof. Lim Soon Thye specialises in lymphoma cancer and lymphoid malignancies. His clinical interest at NCCS is specifically lymphoma, with a particular research and clinical focus on T-cell lymphoma, NK/T-cell lymphoma, and related blood cancers within the lymphoid spectrum.
Prof. Lim practises at the National Cancer Centre Singapore (NCCS) as Chief Executive Officer and Senior Consultant in Medical Oncology. He is also listed as Senior Consultant at the SingHealth Duke-NUS Blood Cancer Centre.
CancerFax can coordinate medical report review and consultation support for international patients seeking an opinion from Prof. Lim Soon Thye at National Cancer Centre Singapore, subject to hospital appointment availability and case acceptance processes.
Submit your medical reports through CancerFax using the Send Your Reports button. The CancerFax team will review your documents, prepare a structured case summary, and coordinate the next steps with NCCS on your behalf, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's histopathology and immunohistochemistry reports, imaging, prior treatment records, and molecular profiling results where available. The consultation format and availability are subject to NCCS processes.
Yes. Prof. Lim leads the NMRC-funded National Lymphoma Translational Research Program and co-founded the Asian Lymphoma Study Group. His team has also led T-cell lymphoma genomics work connected to the International Cancer Genome Consortium. His Google Scholar profile records over 11,000 citations and an h-index of 57.
Connect with Soon Thye Lim Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.